Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking alpha- and beta1-syntrophins

Human Molecular Genetics
Terry ShiaoJames G Tidball

Abstract

Muscular dystrophies that arise from mutations of genes that encode proteins in the dystrophin-glycoprotein complex (DGC) frequently involve defects in the structure of neuromuscular junctions (NMJs). DGC mutations that cause NMJ defects typically cause a secondary loss of neuronal nitric oxide synthase (nNOS) from the post-synaptic membrane. We tested the hypothesis that reduction of muscle-derived NO production causes NMJ defects in DGC mutants by analyzing the effect of modulating muscle NO production on NMJ structure in mutant and wild-type muscles. We found that nNOS null mutants, dystrophin-deficient mdx mice and alpha-syntrophin null mutants showed reductions in the concentration of acetylcholine receptors (AChRs) at the post-synaptic membrane. Also, expression of a muscle-specific NOS transgene increased AChR concentration, which reflected an increase in both AChR expression and clustering. NOS transgene expression also increased the size of NMJs, and partially corrected defects in normal NMJ architecture that were observed in mdx and alpha-syntrophin null muscles. In addition, stimulation of AChR clustering in vitro by application of laminin or VVA B4 lectin induced a 3-4-fold increase in NOS activity and increased ACh...Continue Reading

Citations

Nov 10, 2009·Molecular Neurobiology·Gonneke S K PilgramJasprina N Noordermeer
Aug 10, 2005·Neuro-Signals·Britta PüttmannDieter Blottner
Sep 6, 2007·The Journal of Clinical Investigation·Naoki SuzukiShin'ichi Takeda
Oct 28, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Isabel Martinez-Pena y ValenzuelaMohammed Akaaboune
Jun 7, 2014·Frontiers in Aging Neuroscience·Rüdiger RudolfMichael R Deschenes
May 19, 2006·Muscle & Nerve·Maria Julia MarquesHumberto Santo Neto
May 12, 2007·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Maria Julia MarquesHumberto Santo Neto
Nov 20, 2008·Muscle & Nerve·Paulo C GhediniCaden Souccar
Feb 19, 2009·Developmental Neurobiology·Bradley T Pawlikowski, Margaret M Maimone
Mar 15, 2006·The Journal of Biological Chemistry·Mathieu R Tremblay, Salvatore Carbonetto
Nov 11, 2006·Journal of Applied Physiology·James G Tidball, Michelle Wehling-Henricks
Oct 30, 2012·Journal of Muscle Research and Cell Motility·Jong-Hee KimJohn M Lawler
Oct 31, 2012·The Journal of Physiology·Stephen J P PrattRichard M Lovering
Jun 20, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Antonios MatsakasVihang Narkar
Feb 9, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jonathan D ArcherJudy E Anderson
Oct 27, 2017·Annals of the New York Academy of Sciences·Marta Gawor, Tomasz J Prószyński
Jan 21, 2021·Clinical Epigenetics·Anna RugowskaPatryk Konieczny
Aug 8, 2021·International Journal of Molecular Sciences·Shama R IyerRichard M Lovering
Jan 28, 2009·Molecular and Cellular Neurosciences·Glen B BanksStanley C Froehner
Aug 21, 2020·Neuroscience Letters·Richard M LoveringKay E Davies

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.